Cargando…
Mesenchymal Stem Cell Infusion Shows Promise for Combating Coronavirus (COVID-19)- Induced Pneumonia
A new study published by the journal Aging & Disease reported that intravenous administration of clinical-grade human mesenchymal stem cells (MSCs) into patients with coronavirus disease 2019 (COVID-19) resulted in improved functional outcomes (Leng et al., Aging Dis, 11:216-228, 2020). This stu...
Autor principal: | Shetty, Ashok K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JKL International LLC
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7069463/ https://www.ncbi.nlm.nih.gov/pubmed/32257554 http://dx.doi.org/10.14336/AD.2020.0301 |
Ejemplares similares
-
Combating COVID-19 With Mesenchymal Stem/Stromal Cell Therapy: Promise and Challenges
por: Wang, Shihua H., et al.
Publicado: (2021) -
Further validation of the efficacy of mesenchymal stem cell infusions for reducing mortality in COVID-19 patients with ARDS
por: Shetty, Ashok K., et al.
Publicado: (2021) -
Mesenchymal stem cells in the treatment of coronavirus-induced pneumonia (COVID-19)
por: Mazzeo, Angela, et al.
Publicado: (2020) -
Mesenchymal Stem Cells in the Treatment of New Coronavirus Pandemic: A Novel Promising Therapeutic Approach
por: Razi, Sara, et al.
Publicado: (2022) -
Combating COVID-19 with mesenchymal stem cell therapy
por: Rajarshi, Keshav, et al.
Publicado: (2020)